FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016306263> ?p ?o ?g. }

• W2016306263 endingPage "536" @default.
• W2016306263 startingPage "529" @default.
• W2016306263 abstract "Post-transplant lymphoproliferative disorder (PTLD) complicates 1 to 10% of all transplantations. Previous clinicopathological studies of PTLD have been limited by small numbers, short follow-up times, outdated data, heterogeneity of pooled solid-organ transplant results, and selective inclusion of early-onset disease. We therefore undertake here a retrospective analysis and identify all cases of PTLD that complicated renal transplantation at the Princess Alexandra Hospital between 30 June 1969 and 31 May 2001. Tumour samples were subsequently retrieved for pathological review and for Epstein-Barr virus-encoded RNA in situ hybridisation (EBER-ISH). Of 2,030 renal transplantation patients, 29 (1.4%) developed PTLD after a median period of 0.5 years (range 0.1 to 23.3 years). PTLD patients were more likely to have received cyclosporine (76% versus 62%, P<0.05), tacrolimus (10% versus 2%, P<0.05) and OKT3 (28% versus 10%, P<0.01). As the burden of immunosuppression increased from dual, to triple, to OKT3 therapy, the risks of early onset, extensive-stage, polymorphic, Epstein-Barr virus (EBV)-associated and fatal PTLD progressively increased. The majority of patients presented with an extra-nodal mass (45%), were afebrile (76%), and had stage-IV disease (60%). EBER-ISH was positive in 58%. Actuarial 5-year disease-free survival was 53.7%. The independent predictors of mortality on multivariate Cox regression were polymorphic histology (HR 7.4, 95% CI 1.5-37) and an international prognostic index (IPI) >1 (HR 2.7, 95% CI 1.1-6.8). Compared with other treatments, chemotherapy was associated with higher survival rates (100% versus 18% at 3 years, P=0.0001). In conclusion, PTLD is more likely, occurs earlier, and is more often fatal, in the setting of intensive immunosuppression. Nevertheless, excellent long-term outcomes are achievable with early recognition and institution of appropriate treatment." @default.
• W2016306263 created "2016-06-24" @default.
• W2016306263 creator A5004258581 @default.
• W2016306263 creator A5015788445 @default.
• W2016306263 creator A5020985483 @default.
• W2016306263 creator A5027054405 @default.
• W2016306263 creator A5048539004 @default.
• W2016306263 creator A5051046628 @default.
• W2016306263 creator A5053260042 @default.
• W2016306263 creator A5064897513 @default.
• W2016306263 creator A5065976188 @default.
• W2016306263 creator A5069389082 @default.
• W2016306263 creator A5071255453 @default.
• W2016306263 creator A5082309685 @default.
• W2016306263 creator A5087336965 @default.
• W2016306263 date "2003-07-01" @default.
• W2016306263 modified "2023-10-05" @default.
• W2016306263 title "A single-centre experience of post-renal transplant lymphoproliferative disorder" @default.
• W2016306263 cites W1503584616 @default.
• W2016306263 cites W158940948 @default.
• W2016306263 cites W172184718 @default.
• W2016306263 cites W1908565253 @default.
• W2016306263 cites W1911120442 @default.
• W2016306263 cites W1928226181 @default.
• W2016306263 cites W1933173616 @default.
• W2016306263 cites W1941912137 @default.
• W2016306263 cites W1968633192 @default.
• W2016306263 cites W1972997823 @default.
• W2016306263 cites W1977635228 @default.
• W2016306263 cites W1989390667 @default.
• W2016306263 cites W1991356164 @default.
• W2016306263 cites W2009844134 @default.
• W2016306263 cites W2022437745 @default.
• W2016306263 cites W2026689623 @default.
• W2016306263 cites W2028269517 @default.
• W2016306263 cites W2029173475 @default.
• W2016306263 cites W2048140210 @default.
• W2016306263 cites W2065123216 @default.
• W2016306263 cites W2069881622 @default.
• W2016306263 cites W2073920357 @default.
• W2016306263 cites W2075300305 @default.
• W2016306263 cites W2077910054 @default.
• W2016306263 cites W2080062050 @default.
• W2016306263 cites W2082590264 @default.
• W2016306263 cites W2084630860 @default.
• W2016306263 cites W2087824134 @default.
• W2016306263 cites W2095417318 @default.
• W2016306263 cites W2099855280 @default.
• W2016306263 cites W2112276914 @default.
• W2016306263 cites W2131598459 @default.
• W2016306263 cites W2133229848 @default.
• W2016306263 cites W2137858837 @default.
• W2016306263 cites W2139033805 @default.
• W2016306263 cites W2153569820 @default.
• W2016306263 cites W2171464968 @default.
• W2016306263 cites W2273980314 @default.
• W2016306263 cites W2302484801 @default.
• W2016306263 cites W2341259055 @default.
• W2016306263 cites W2405476713 @default.
• W2016306263 cites W2410302560 @default.
• W2016306263 cites W2411444202 @default.
• W2016306263 cites W2415872399 @default.
• W2016306263 cites W2419301860 @default.
• W2016306263 cites W2437132688 @default.
• W2016306263 cites W2437832119 @default.
• W2016306263 cites W2461447842 @default.
• W2016306263 cites W2605539363 @default.
• W2016306263 cites W2764347834 @default.
• W2016306263 cites W2418759173 @default.
• W2016306263 doi "https://doi.org/10.1007/s00147-003-0596-0" @default.
• W2016306263 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12734646" @default.
• W2016306263 hasPublicationYear "2003" @default.
• W2016306263 type Work @default.
• W2016306263 sameAs 2016306263 @default.
• W2016306263 citedByCount "12" @default.
• W2016306263 countsByYear W20163062632014 @default.
• W2016306263 countsByYear W20163062632016 @default.
• W2016306263 countsByYear W20163062632018 @default.
• W2016306263 countsByYear W20163062632022 @default.
• W2016306263 crossrefType "journal-article" @default.
• W2016306263 hasAuthorship W2016306263A5004258581 @default.
• W2016306263 hasAuthorship W2016306263A5015788445 @default.
• W2016306263 hasAuthorship W2016306263A5020985483 @default.
• W2016306263 hasAuthorship W2016306263A5027054405 @default.
• W2016306263 hasAuthorship W2016306263A5048539004 @default.
• W2016306263 hasAuthorship W2016306263A5051046628 @default.
• W2016306263 hasAuthorship W2016306263A5053260042 @default.
• W2016306263 hasAuthorship W2016306263A5064897513 @default.
• W2016306263 hasAuthorship W2016306263A5065976188 @default.
• W2016306263 hasAuthorship W2016306263A5069389082 @default.
• W2016306263 hasAuthorship W2016306263A5071255453 @default.
• W2016306263 hasAuthorship W2016306263A5082309685 @default.
• W2016306263 hasAuthorship W2016306263A5087336965 @default.
• W2016306263 hasConcept C126322002 @default.
• W2016306263 hasConcept C146357865 @default.
• W2016306263 hasConcept C151730666 @default.
• W2016306263 hasConcept C167135981 @default.
• W2016306263 hasConcept C2776995267 @default.

• next